UBISOFT ENTERTAINMENT (UBI.PA) Fundamental Analysis & Valuation

EPA:UBI • FR0000054470

Current stock price

4.029 EUR
-0.14 (-3.38%)
Last:

This UBI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. UBI.PA Profitability Analysis

1.1 Basic Checks

  • UBI had negative earnings in the past year.
  • UBI had a positive operating cash flow in the past year.
  • In multiple years UBI reported negative net income over the last 5 years.
  • In the past 5 years UBI always reported a positive cash flow from operatings.
UBI.PA Yearly Net Income VS EBIT VS OCF VS FCFUBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.71%, UBI is in line with its industry, outperforming 52.27% of the companies in the same industry.
  • UBI's Return On Equity of -4.71% is in line compared to the rest of the industry. UBI outperforms 56.82% of its industry peers.
  • The Return On Invested Capital of UBI (2.04%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.71%
ROE -4.71%
ROIC 2.04%
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
UBI.PA Yearly ROA, ROE, ROICUBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • UBI has a Operating Margin of 5.87%. This is in the better half of the industry: UBI outperforms 68.18% of its industry peers.
  • Looking at the Gross Margin, with a value of 89.78%, UBI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of UBI has remained more or less at the same level.
Industry RankSector Rank
OM 5.87%
PM (TTM) N/A
GM 89.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
UBI.PA Yearly Profit, Operating, Gross MarginsUBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. UBI.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so UBI is destroying value.
  • UBI has more shares outstanding than it did 1 year ago.
  • UBI has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for UBI has been reduced compared to a year ago.
UBI.PA Yearly Shares OutstandingUBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
UBI.PA Yearly Total Debt VS Total AssetsUBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • UBI has an Altman-Z score of 0.96. This is a bad value and indicates that UBI is not financially healthy and even has some risk of bankruptcy.
  • UBI has a Altman-Z score (0.96) which is in line with its industry peers.
  • The Debt to FCF ratio of UBI is 2.65, which is a good value as it means it would take UBI, 2.65 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of UBI (2.65) is better than 63.64% of its industry peers.
  • UBI has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • UBI has a Debt to Equity ratio (1.11) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 2.65
Altman-Z 0.96
ROIC/WACC0.38
WACC5.37%
UBI.PA Yearly LT Debt VS Equity VS FCFUBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.18 indicates that UBI should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.18, UBI is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • UBI has a Quick Ratio of 1.17. This is a normal value and indicates that UBI is financially healthy and should not expect problems in meeting its short term obligations.
  • UBI's Quick ratio of 1.17 is fine compared to the rest of the industry. UBI outperforms 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.17
UBI.PA Yearly Current Assets VS Current LiabilitesUBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. UBI.PA Growth Analysis

3.1 Past

  • The earnings per share for UBI have decreased strongly by -207.14% in the last year.
  • UBI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.78%.
  • The Revenue has been growing slightly by 3.56% on average over the past years.
EPS 1Y (TTM)-207.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-11.78%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%2.41%

3.2 Future

  • UBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.39% yearly.
  • The Revenue is expected to grow by 3.65% on average over the next years.
EPS Next Y-910.84%
EPS Next 2Y34.5%
EPS Next 3Y39.77%
EPS Next 5Y26.39%
Revenue Next Year-19.4%
Revenue Next 2Y-5.79%
Revenue Next 3Y-1.92%
Revenue Next 5Y3.65%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
UBI.PA Yearly Revenue VS EstimatesUBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
UBI.PA Yearly EPS VS EstimatesUBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

3

4. UBI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • UBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year UBI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UBI.PA Price Earnings VS Forward Price EarningsUBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UBI is valued cheaply inside the industry as 86.36% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, UBI is valued cheaply inside the industry as 95.45% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.69
EV/EBITDA 3.39
UBI.PA Per share dataUBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • UBI's earnings are expected to grow with 39.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.5%
EPS Next 3Y39.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. UBI.PA Dividend Analysis

5.1 Amount

  • No dividends for UBI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UBI.PA Fundamentals: All Metrics, Ratios and Statistics

UBISOFT ENTERTAINMENT

EPA:UBI (3/18/2026, 7:00:00 PM)

4.029

-0.14 (-3.38%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-12
Earnings (Next)05-12
Inst Owners38.24%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap542.87M
Revenue(TTM)1.89B
Net Income(TTM)-73.60M
Analysts50.91
Price Target6.17 (53.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.74%
PT rev (3m)-37.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-940.46%
EPS NY rev (3m)-925.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-15.84%
Revenue NY rev (3m)-15.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF 0.69
P/OCF 0.66
P/B 0.35
P/tB N/A
EV/EBITDA 3.39
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)5.84
FCFY145.01%
OCF(TTM)6.08
OCFY150.92%
SpS13.99
BVpS11.6
TBVpS-6.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.71%
ROE -4.71%
ROCE 3.3%
ROIC 2.04%
ROICexc 2.18%
ROICexgc 9.5%
OM 5.87%
PM (TTM) N/A
GM 89.78%
FCFM 41.76%
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 2.65
Debt/EBITDA 2.4
Cap/Depr 5.27%
Cap/Sales 1.7%
Interest Coverage 250
Cash Conversion 113.81%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.17
Altman-Z 0.96
F-Score3
WACC5.37%
ROIC/WACC0.38
Cap/Depr(3y)8.81%
Cap/Depr(5y)10.92%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-207.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-910.84%
EPS Next 2Y34.5%
EPS Next 3Y39.77%
EPS Next 5Y26.39%
Revenue 1Y (TTM)-11.78%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%2.41%
Revenue Next Year-19.4%
Revenue Next 2Y-5.79%
Revenue Next 3Y-1.92%
Revenue Next 5Y3.65%
EBIT growth 1Y110.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year913.18%
EBIT Next 3Y144.32%
EBIT Next 5Y85.02%
FCF growth 1Y94.95%
FCF growth 3Y16.28%
FCF growth 5Y14.31%
OCF growth 1Y79.44%
OCF growth 3Y12.65%
OCF growth 5Y10.94%

UBISOFT ENTERTAINMENT / UBI.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UBISOFT ENTERTAINMENT?

ChartMill assigns a fundamental rating of 3 / 10 to UBI.PA.


What is the valuation status for UBI stock?

ChartMill assigns a valuation rating of 3 / 10 to UBISOFT ENTERTAINMENT (UBI.PA). This can be considered as Overvalued.


How profitable is UBISOFT ENTERTAINMENT (UBI.PA) stock?

UBISOFT ENTERTAINMENT (UBI.PA) has a profitability rating of 3 / 10.